Abstract:Hepatocellular carcinoma related protein 1 (HCRP1), which is essential for internalization and degradation of ubiquitinated membrane receptors, is downregulated in several tumors and strongly affects the outcomes of cancer patients. It is reported the expression of HCRP1 is inversely related to epidermal growth factor receptor (EGFR) in breast cancer and lead to resistance to cetuximab in ovarian cancer. However, its exact mechanism in the progression of Hepatocellular carcinoma (HCC) remains unknown. Herein, HCRP1 expression and its clinical significance were examined in 101 HCC patients using immunohistochemistry. Cell proliferation, migration and invasion assays were conducted in HCC cell lines. EGFR activation and degradation were then observed after EGF inducing in HCRP1 knockdown HepG2 cells. In addition, we also detected whether epithelial-to-mesenchymal transition (EMT) was involved in the malignancy promoted by HCRP1. The results showed that 59 of the 101 HCC cases exhibited downregulation of HCRP1 expression (P<0.01) as compared to 30 benign liver lesions and 20 normal liver tissues, all of which showed a high level of HCRP1. HCRP1 expression was significantly related to age (P=0.017), pathological grade (P=0.003), tumor encapsulation (P=0.037), recurrence (P=0.039) and death (P=0.015), but unrelated to cirrhosis (P=0.216), tumor size (P=0.273), and distant metastasis (P=0.554). Lower HCRP1 expression was correlated with shorter RFS and OS (P<0.001), and decreased HCRP1 level is an independent prognostic marker in HCC patients (P<0.05). Overexpression of HCRP1 decreased and knockdown increased HCC cell proliferation, migration and invasion. HCRP1 depletion increased EGFR activation and inhibited EGFR degradation. EMT phenotype was promoted after HCRP1 downregulation via increase of Snail and Twist1 and activation of Akt phosphorylation in HepG2 cells. Conversely, upregulation of HCRP1 in SMMC-7721 cells led to the opposite effect. In conclusion, our study indicated that downregulation of HCRP1 is a valuable prognostic factor involved in EGFR regulation and acquisition of the mesenchymal phenotype of HCC cells.

Downregulation of PRRX1 Via the P53-Dependent Signaling Pathway Predicts Poor Prognosis in Hepatocellular Carcinoma.

PRRX1 Deficiency Induces Mesenchymal‐epithelial Transition Through PITX2/miR‐200–dependent SLUG/CTNNB1 Regulation in Hepatocellular Carcinoma

PRR7-AS1 Correlates with Immune Cell Infiltration and is a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.

Proline-rich Protein 11 Silencing Inhibits Hepatocellular Carcinoma Growth and Epithelial-Mesenchymal Transition Through Β-Catenin Signaling.

Peroxiredoxin2 downregulation enhances hepatocellular carcinoma proliferation and migration, and is associated with unfavorable prognosis in patients.

p53-induced RING-H2 protein, a novel marker for poor survival in hepatocellular carcinoma after hepatic resection.

HCRP1 Downregulation Promotes Hepatocellular Carcinoma Cell Migration and Invasion Through the Induction of EGFR Activation and Epithelial-Mesenchymal Transition.

Downregulation of Long Non-Coding RNAs JPX and XIST is Associated with the Prognosis of Hepatocellular Carcinoma.

PEBP1 Downregulation is Associated to Poor Prognosis in HCC Related to Hepatitis B Infection

Tp53inp1 Downregulation Activates A P73-Dependent Dusp10/Erk Signaling Pathway to Promote Metastasis of Hepatocellular Carcinoma

Decreased HCRP 1 Expression is Associated with Poor Prognosis in Breast Cancer Patients

Down-Regulation Of Hopx Associates With Poor Prognosis Of Human Hepatocellular Carcinoma

Loss of RDM1 Enhances Hepatocellular Carcinoma Progression Via P53 and Ras/Raf/ERK Pathways

Plexin domain-containing 1 may be a biomarker of poor prognosis in hepatocellular carcinoma patients, may mediate immune evasion

Low Level of Low-Density Lipoprotein Receptor-Related Protein 1 Predicts an Unfavorable Prognosis of Hepatocellular Carcinoma after Curative Resection.

Downregulation of C1R promotes hepatocellular carcinoma development by activating HIF‐1α‐regulated glycolysis

Decreased Expression of Peroxisome Proliferator-Activated Receptor Alpha Indicates Unfavorable Outcomes in Hepatocellular Carcinoma

Analysis of Transcriptome in the Relationship Between Expression of PRC1 Protein and Prognosis of Patients with Cholangiocarcinoma

The Regulatory Role of PRRX1 in Cancer Epithelial-Mesenchymal Transition.

URM1 Promoted Tumor Growth and Suppressed Apoptosis via the JNK Signaling Pathway in Hepatocellular Carcinoma

Pan-Cancer Analysis Reveals PPRC1 as a Novel Prognostic Biomarker in Ovarian Cancer and Hepatocellular Carcinoma